PL362279A1 - Preparaty dermatologiczne - Google Patents

Preparaty dermatologiczne

Info

Publication number
PL362279A1
PL362279A1 PL36227901A PL36227901A PL362279A1 PL 362279 A1 PL362279 A1 PL 362279A1 PL 36227901 A PL36227901 A PL 36227901A PL 36227901 A PL36227901 A PL 36227901A PL 362279 A1 PL362279 A1 PL 362279A1
Authority
PL
Poland
Prior art keywords
dermatological formulations
clindamycin
rosacea
acne
zinc salt
Prior art date
Application number
PL36227901A
Other languages
English (en)
Other versions
PL207221B1 (pl
Inventor
Emma Louise Mcdonagh
Rebecca Louise Kanis
Original Assignee
Kanford B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanford B.V. filed Critical Kanford B.V.
Publication of PL362279A1 publication Critical patent/PL362279A1/pl
Publication of PL207221B1 publication Critical patent/PL207221B1/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
PL362279A 2000-11-28 2001-11-28 Wodny preparat do miejscowego stosowania, sposób wytwarzania preparatu oraz zastosowanie preparatu do otrzymania leku do leczenia stanu dermatologicznego PL207221B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0029018.9A GB0029018D0 (en) 2000-11-28 2000-11-28 Dermatological formulations
PCT/GB2001/005257 WO2002043739A2 (en) 2000-11-28 2001-11-28 Dermatological formulations containing clindamycin and a zinc-salt

Publications (2)

Publication Number Publication Date
PL362279A1 true PL362279A1 (pl) 2004-10-18
PL207221B1 PL207221B1 (pl) 2010-11-30

Family

ID=9904040

Family Applications (1)

Application Number Title Priority Date Filing Date
PL362279A PL207221B1 (pl) 2000-11-28 2001-11-28 Wodny preparat do miejscowego stosowania, sposób wytwarzania preparatu oraz zastosowanie preparatu do otrzymania leku do leczenia stanu dermatologicznego

Country Status (24)

Country Link
US (2) US20040109902A1 (pl)
EP (1) EP1347765B1 (pl)
JP (1) JP4272425B2 (pl)
KR (1) KR100629326B1 (pl)
AT (1) ATE321560T1 (pl)
AU (2) AU2309102A (pl)
BR (1) BR0115727A (pl)
CA (1) CA2429205C (pl)
CZ (1) CZ305272B6 (pl)
DE (1) DE60118441T2 (pl)
DK (1) DK1347765T3 (pl)
ES (1) ES2263689T3 (pl)
GB (1) GB0029018D0 (pl)
HR (1) HRP20030433B1 (pl)
HU (1) HUP0400520A3 (pl)
IL (1) IL152720A0 (pl)
MX (1) MXPA03004733A (pl)
NZ (1) NZ526170A (pl)
PL (1) PL207221B1 (pl)
PT (1) PT1347765E (pl)
RU (1) RU2277419C2 (pl)
SK (1) SK288111B6 (pl)
WO (1) WO2002043739A2 (pl)
ZA (1) ZA200305012B (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101324578B1 (ko) 2006-02-03 2013-11-01 제이알 켐, 엘엘씨 구리 및 아연 조성물을 사용하는 노화 방지 치료법
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
JP5244917B2 (ja) * 2007-11-30 2013-07-24 ノバルティス アーゲー C2−c5−アルキル−イミダゾール−ビスホスホネート類
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
CA2750636C (en) 2009-01-23 2017-07-25 Jr Chem, Llc Rosacea treatments and kits for performing them
AU2010238566B2 (en) * 2010-11-01 2012-09-20 Stiefel Research Australia Pty Ltd Polymeric topical compositions
US8481591B2 (en) 2010-11-01 2013-07-09 Stiefel Research Australia Pty. Ltd. Polymeric topical compositions
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
US9023399B2 (en) 2012-11-16 2015-05-05 NU Technology, LLC Water-soluble anti-inflammatory cream with natural ingredients base
US8613961B1 (en) 2013-01-09 2013-12-24 NU Technology, LLC Dermatological cream with natural ingredients base
CN109498564B (zh) * 2018-12-21 2021-04-16 贵州景峰注射剂有限公司 一种克林霉素磷酸酯配液及其制备方法
US20230000892A1 (en) * 2021-06-30 2023-01-05 Kenneth Okafor Solution, Lotion, Gel, and Cream for Use to Prevent Razor Bumps

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3969516A (en) * 1974-12-19 1976-07-13 Nelson Research & Development Company Composition and method for treatment of acne
US4621075A (en) * 1984-11-28 1986-11-04 The Procter & Gamble Company Gel-form topical antibiotic compositions
US4895727A (en) * 1985-05-03 1990-01-23 Chemex Pharmaceuticals, Inc. Pharmaceutical vehicles for exhancing penetration and retention in the skin
JPS6251619A (ja) * 1985-08-30 1987-03-06 Wako Pure Chem Ind Ltd 外用ゲル製剤
TW203552B (en) * 1992-02-18 1993-04-11 J Baroody Lloyd Compositions of clindamycin and benzoyl peroxide for acne treatment
JP3981151B2 (ja) * 1994-03-28 2007-09-26 ザ トラスティーズ オブ コロンビア ユニバーシティー イン ザ シティー オブ ニューヨーク 液体中の刺激物を不活化するための組成物
FR2728166A1 (fr) * 1994-12-19 1996-06-21 Oreal Composition topique contenant un antagoniste de substance p
US5648389A (en) * 1995-10-27 1997-07-15 Medicis Pharmaceutical, Inc. Compositions for the treatment of dermatological disorders and methods for their use

Also Published As

Publication number Publication date
MXPA03004733A (es) 2005-02-14
SK288111B6 (sk) 2013-08-02
NZ526170A (en) 2006-01-27
BR0115727A (pt) 2003-10-14
JP2004517829A (ja) 2004-06-17
HRP20030433B1 (hr) 2007-10-31
US20040109902A1 (en) 2004-06-10
EP1347765A2 (en) 2003-10-01
US8268790B2 (en) 2012-09-18
CZ305272B6 (cs) 2015-07-15
WO2002043739A2 (en) 2002-06-06
IL152720A0 (en) 2003-06-24
HRP20030433A2 (en) 2004-08-31
AU2002223091B2 (en) 2006-08-31
HUP0400520A2 (hu) 2004-07-28
SK6322003A3 (en) 2003-12-02
JP4272425B2 (ja) 2009-06-03
RU2277419C2 (ru) 2006-06-10
PT1347765E (pt) 2006-08-31
EP1347765B1 (en) 2006-03-29
DE60118441D1 (de) 2006-05-18
US20100173855A1 (en) 2010-07-08
AU2309102A (en) 2002-06-11
DK1347765T3 (da) 2006-08-07
CZ20031491A3 (cs) 2004-01-14
WO2002043739A3 (en) 2003-05-01
ATE321560T1 (de) 2006-04-15
GB0029018D0 (en) 2001-01-10
KR20030069793A (ko) 2003-08-27
CA2429205A1 (en) 2002-06-06
KR100629326B1 (ko) 2006-09-29
HUP0400520A3 (en) 2012-08-28
CA2429205C (en) 2010-11-16
ES2263689T3 (es) 2006-12-16
DE60118441T2 (de) 2006-11-16
PL207221B1 (pl) 2010-11-30
ZA200305012B (en) 2005-04-26
HK1059218A1 (en) 2004-06-25

Similar Documents

Publication Publication Date Title
AU2309102A (en) Dermatological formulations
WO2006055008A3 (en) Implantable sensors and implantable pumps and anti-scarring agents
WO2003032941A3 (de) Kosmetische und/oder dermatologische wirkstoffkombination
WO1996003151A3 (en) Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy
WO2002062775A1 (en) 2-acylaminothiazole derivative or its salt
WO2000040266A3 (en) Targeting of sebaceous follicles as a treatment of sebaceous gland disorders
DE69900081D1 (de) Haut- und/oder Haardepigmentierungsmittel
WO2004021968A3 (en) Solution for ungual application
AU2001282399A1 (en) Resorcinol derivatives
TW200612966A (en) Boron-containing compounds and methods of use
WO2001072264A3 (de) Pro-liposomal verkapselte zubereitungen (iv)
WO2004009038A3 (de) Kosmetische zubereitungen mit antibakteriellen eigenschaften glyzyrrhetinsäure enthaltend
AU2001289606A1 (en) Dry powder formulation comprising racecadotril
WO2003053180A3 (de) Wirkstoffhaltige unterwäsche
WO2007065289A3 (en) 4-oxo-(iso)tretinoin for the topical treatment of severe dermatological disorders
WO2001062208A3 (de) Topische kosmetische mittel enthaltend 2-hydrazino-1,3-heteroazole
ES2137125A1 (es) La utilizacion de la sal de zinc del acido glicirretico en preparados contra el acne y las composiciones que contienen dicha sal.
AU2003210383A1 (en) Low ph, high skin friction cosmetic creams
WO2003007900A3 (en) Skin treatment
WO2003011241A8 (de) Verwendung von kreatinin und/oder kreatininderivaten in kosmetischen oder dermatologischen zubereitungen
AU5487101A (en) Cosmetic or dermatological product comprising a freeze-dried hydrocolloid composition
AU2001285944A1 (en) Fungicidal agent containing n-chlorotaurine and use thereof
AU2002366530A1 (en) Utilization of dihydropinosylvin and derivatives thereof as tyrosinase inhibitors for skin lightening or as antimicrobial substances for preservation or for the treatment of acne, dandruff or body odors
AR034554A1 (es) Un metodo para mejorar la distribucion de un ingrediente activo en un licor de curtido, una tableta o bloque para ser usado en dicho metodo, y el uso de dicha tableta o bloque en el curtido de cuero
WO2002072039A3 (en) Topical preparations and food preparations comprising a pyridoxine-alpha-d-glucose